Triaminic Vapor Patch cough-suppressant recalled. Novartis AG said it has started to recall its Triaminic Vapor Patch cough-suppressant because of potential health threat to children who might remove it and chew on the patch.
Vapor Patch is widely available in the US and sold over the counter.
The US Food and Drug Administration has registered the recall, Novartis said. The recall was considered a welcome development as many Americans are supporting the recall process to safeguard patients and stakeholders. Many even thought that the recall procedure will also teach a lesson that health and safety of patients and whoever will use the product. The cough-suppressant Triaminic Vapor Patch may also threaten other illnesses.
the recalled patch is not safe for use
It would be very risky to patients if the recall will not happen because the patch is not safety for use. The decision made by the US Food and Drug Administration also get positive reactions among the citizens in the US territory and other countries of the world.